Cite
The degree of HLA matching determines the incidence of cytokine release syndrome and associated nonrelapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide.
MLA
von dem Borne, Peter A., et al. “The Degree of HLA Matching Determines the Incidence of Cytokine Release Syndrome and Associated Nonrelapse Mortality in Matched Related and Unrelated Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide.” Leukemia & Lymphoma, May 2024, pp. 1–11. EBSCOhost, https://doi.org/10.1080/10428194.2024.2344060.
APA
von dem Borne, P. A., Kemps-Mols, B. M., de Wreede, L. C., van Beek, A. A., Snijders, T. J. F., van Lammeren, D., Tijmensen, J., Sijs-Szabó, A., Oudshoorn, M. A., Halkes, C. J. ., van Balen, P., Marijt, W. A. E., Tjon, J. M. L., Vermaat, J. S. ., & Veelken, H. (2024). The degree of HLA matching determines the incidence of cytokine release syndrome and associated nonrelapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide. Leukemia & Lymphoma, 1–11. https://doi.org/10.1080/10428194.2024.2344060
Chicago
von dem Borne, Peter A., Berit M. Kemps-Mols, Liesbeth C. de Wreede, Adriaan A. van Beek, Tjeerd J.F. Snijders, Daniëlle van Lammeren, Janneke Tijmensen, et al. 2024. “The Degree of HLA Matching Determines the Incidence of Cytokine Release Syndrome and Associated Nonrelapse Mortality in Matched Related and Unrelated Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide.” Leukemia & Lymphoma, May, 1–11. doi:10.1080/10428194.2024.2344060.